Literature DB >> 19269818

Inhibition of NF-kB and metalloproteinase-9 expression and secretion by parthenolide derivatives.

Mario Dell'Agli1, Germana V Galli, Enrica Bosisio, Michele D'Ambrosio.   

Abstract

Semisynthetic derivatives of parthenolide (1) were tested on NF-kB driven transcription and metalloproteinase-9 (MMP-9) expression and secretion. The four membered ring compounds 5 and 6, obtained by acidic treatment of 1, exhibited a higher activity with respect to 1 in all the biological assays. Then an increased ability of the 5 and 6 to inhibit NF-kB driven transcription may lead to a down-regulation of MMP-9 expression and secretion. This work provides new details about the structural requisites for NF-kB inhibition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19269818     DOI: 10.1016/j.bmcl.2009.02.080

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

1.  Cell context-dependent activities of parthenolide in primary and metastatic melanoma cells.

Authors:  M Czyz; K Lesiak-Mieczkowska; K Koprowska; A Szulawska-Mroczek; M Wozniak
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  Heck products of parthenolide and melampomagnolide-B as anticancer modulators that modify cell cycle progression.

Authors:  Narsimha R Penthala; Shobanbabu Bommagani; Venumadhav Janganati; Kenzie B MacNicol; Chad E Cragle; Nikhil R Madadi; Linda L Hardy; Angus M MacNicol; Peter A Crooks
Journal:  Eur J Med Chem       Date:  2014-08-07       Impact factor: 6.514

3.  RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulation.

Authors:  Can Lu; Li-Yan Zhou; Hui-Jun Xu; Xing-Yu Chen; Zhong-Sheng Tong; Xiao-Dong Liu; Yong-Sheng Jia; Yue Chen
Journal:  Acta Pharmacol Sin       Date:  2014-06-09       Impact factor: 6.150

4.  Nitroglycerin alters matrix remodeling proteins in THP-1 human macrophages and plasma metalloproteinase activity in rats.

Authors:  Anu Shilpa Krishnatry; Sun Mi Fung; Daniel A Brazeau; David Soda; Ho-Leung Fung
Journal:  Nitric Oxide       Date:  2010-12-13       Impact factor: 4.427

5.  Synthesis and antileukemic activities of C1-C10-modified parthenolide analogues.

Authors:  Aaron M Kempema; John C Widen; Joseph K Hexum; Timothy E Andrews; Dan Wang; Susan K Rathe; Frederick A Meece; Klara E Noble; Zohar Sachs; David A Largaespada; Daniel A Harki
Journal:  Bioorg Med Chem       Date:  2015-05-30       Impact factor: 3.641

6.  Endogenous matrix metalloproteinases 2 and 9 regulate activation of CD4+ and CD8+ T cells.

Authors:  Heather L Benson; Shahriar Mobashery; Mayland Chang; Farrah Kheradmand; Jeong Soo Hong; Gerald N Smith; Rebecca A Shilling; David S Wilkes
Journal:  Am J Respir Cell Mol Biol       Date:  2010-07-16       Impact factor: 6.914

7.  Correlation between catechin content and NF-κB inhibition by infusions of green and black tea.

Authors:  Chiara Di Lorenzo; Mario Dell'Agli; Enrico Sangiovanni; Ariana Dos Santos; Francesca Uberti; Enzo Moro; Enrica Bosisio; Patrizia Restani
Journal:  Plant Foods Hum Nutr       Date:  2013-06       Impact factor: 3.921

8.  IL-33 Can Promote the Process of Pulmonary Fibrosis by Inducing the Imbalance Between MMP-9 and TIMP-1.

Authors:  Liyan Wu; Zujin Luo; Jinxu Zheng; Peng Yao; Zhenyan Yuan; Xiaohong Lv; Jing Zhao; Min Wang
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

9.  Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis.

Authors:  Zhihui Zhang; Kai Zhang; Mi Zhang; Xiaomin Zhang; Rongxin Zhang
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

10.  Micheliolide derivative DMAMCL inhibits glioma cell growth in vitro and in vivo.

Authors:  Yinghong An; Wanjun Guo; Linna Li; Chengwang Xu; Dexuan Yang; Shanshan Wang; Yaxin Lu; Quan Zhang; Jiadai Zhai; Hongxia Fan; Chuanjiang Qiu; Jie Qi; Yue Chen; Shoujun Yuan
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.